We are live on ! Find out more
RVLP

RVL Pharmaceuticals plc Ordinary Shares
RVLP

Delisted

RVLP was delisted on the 20th of October, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of RVLP yet.

RVLP Hedge Fund Activity: Q1 2024 in Review

0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q1 2024, worth a combined $0 — down 100% from $613 a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of RVLP and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was XTX Topco, exiting entirely with an estimated $542 sold.

  • 0 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q1 2024, down from 3 in Q4 2023.
  • Funds reported $0 of RVL Pharmaceuticals plc Ordinary Shares stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q1 2024 and 3 closed out, a net change of -3 holders.
  • The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q1 2024 was XTX Topco, an estimated $542 sold.

Based on aggregated 13F filings for Q1 2024.